UK Short-Circuits OTC Device Pain Relief Claims For Diabetics, Arthritics
Executive Summary
Ad claims for Actegy's Revitive Circulation Booster device did not rely on clinical evidence that tested the actual product in the way consumers were advised to use it, UK advertising regulator says. Actegy maintained benefits from the device's TENS technology are similar to the effects of NMES technology used in studies it offered as evidence.
You may also be interested in...
GSK Consumer Tries On Wearable Pain Relief With NeuroMetrix Deal
GSK Consumer purchases ex-US rights to pain relief device Quell from NeuroMetrix in a deal that includes co-development of transcutaneous electrical nerve stimulation products.
Industry Roundup: P&G Leadership, Unilever Sale, Ad Claims
Patterson Medical adds Performance Health; EarlySense targets consumer expansion; faster capsule filler available; and more news in brief.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.